Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Self-controlled comparison of remimazolam and propofol sedation during interstitial brachytherapy for cervical cancer
ChiCTR2200065938Phase 4Completed
- Sponsor
- Sichuan Cancer Hospital
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam and propofol in Cervical Cancer (CC) (3 arms), sponsored by Sichuan Cancer Hospital. Primary endpoints: Blood pressure, Heart rate and 5 more. Started Oct 2022; status: completed.
02
Drugs
remimazolampropofol
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on ChiCTR2200065938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200065938.